Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Researchers stop ovarian cancer cell cycle in its tracks

Ovarian cancer cells are "addicted" to a family of proteins produced by the notorious oncogene, MYC, and blocking these Myc proteins halts cell proliferation in the deadliest cancer of the female reproductive system, according to a presentation by University of California, Berkeley scientists at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.

15 Dec 2008

Conquering cancer: A global effort

Despite the recent good news that cancer incidence and death rates for men and women in the United States continue to decline, cancer is projected to become the leading cause of death worldwide in the year 2010, and low- and middle-income countries will feel the impact of higher cancer incidence and death rates more sharply than industrialized countries.

10 Dec 2008

BD Diagnostics receives FDA approval for imaging system that enhances detection of cervical cancer

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) has announced that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System.

From BD (Becton, Dickinson and Company) 8 Dec 2008

Reactions to HPV vaccine Gardasil rare

Research by Australian scientists has found that adverse reactions to the HPV vaccine Gardasil are rare and most schoolgirls are able to tolerate subsequent doses.

3 Dec 2008

European research effort pushes towards cervical cancer cure

Every year, tens of thousands of women die in the EU from cervical cancer because the disease is not detected and treated at an early enough stage. A multidisciplinary European research effort plans to change that.

2 Dec 2008

Living in deprived areas of England doubles cervical cancer risk

Women living in the most deprived areas of England are nearly twice as likely to be diagnosed with cervical cancer than their affluent counterparts - according to a report presented by national cancer director Professor Mike Richards at the Britain Against Cancer conference today (Tuesday).

2 Dec 2008

Risk of non-AIDS cancer higher for individuals infected with HIV

The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

18 Nov 2008

Researchers say identifying women with HPV types 16, 18 and 45 could improve early intervention to stop cervical cancer

As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the disease and thus are in need of more immediate intervention.

16 Nov 2008

State mandates for HPV vaccination unwarranted and unwise

The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the world.

12 Nov 2008

Expert warns it would be ill-advised to mandate HPV vaccinations at this time

Vaccinating girls against the human papillomavirus (HPV) before they are sexually active appears to be successful in protecting them against cervical cancer, however, a Johns Hopkins University researcher and health policy expert warns it would be ill-advised to mandate vaccinations at this time.

12 Nov 2008

Comprehensive assessment of burden of HPV-associated cancers in the U.S.

Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date.

11 Nov 2008

Number of custodial grandparents in U.S. has nearly doubled since 1970

Precautionary health measures such as mammograms and cholesterol tests that identify the risk of heart disease are critical for the well-being of women over 50.

7 Nov 2008

SWHR asks young women to be aware of smoking dangers in face of new marketing tactics

Society for Women’s Health Research President and CEO Phyllis Greenberger, M.S.W., issued the following statement in response to the decision of Philip Morris USA to introduce pink “Purse Packs” for some Virginia Slims cigarette brands by early 2009.

6 Nov 2008

Most adults not up to date on their vaccinations

Most adults are not up to date on their vaccinations, says a new report from Harvard Medical School.

5 Nov 2008

$Healthy bones program reduces hip fractures by 37 percent$

Healthy bones program reduces hip fractures by 37 percent

Proactive measures can reduce hip fracture rates by an average of 37.2 percent -- and as much as 50 percent -- among those at risk, according to a study conducted by Kaiser Permanente Southern California.

5 Nov 2008

Call to explore broader use of human papillomavirus vaccines

A call to explore a broader use of HPV (human papillomavirus) vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by a Johns Hopkins Kimmel Cancer Center investigator.

4 Nov 2008

Human papillomavirus helps cervical and head and neck cancers resist treatment and grow and spread

The human papillomavirus (HPV) allows infected cervical and head and neck cancer cells to maintain internal molecular conditions that make the cancers resistant to therapy and more likely to grow and spread, resulting in a poor prognosis for patients, researchers with UCLA's Jonsson Cancer Center found.

4 Nov 2008

Scientist says research indicates need for effective HPV vaccine for women and men and a simple HPV screening test

3 Nov 2008

New imaging technique detects early cervical cancer

The Institute of Cancer Research and The Royal Marsden Hospital have developed a new imaging technique which locates previously undetectable early stage cervical cancers, according to research published in Radiology today (October 21).

21 Oct 2008

CDC officials did not know HPV vaccination recommendation for U.S. women also would affect prospective immigrants

Some of the CDC officials who supported a recommendation for young women in the U.S. to receive the human papillomavirus vaccine said they did not intend for it to lead to an immigration policy requiring young immigrant women to receive the vaccine, the Wall Street Journal reports (Jordan, Wall Street Journal, 10/1).

5 Oct 2008